-
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years
Hereditary Angioedema (HAE)
-
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema
Hereditary Angioedema (HAE)
-
The Multifactorial Impact of Receiving a Hereditary Angioedema Diagnosis
Hereditary Angioedema (HAE)
-
Caregivers’ Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burdens
Hereditary Angioedema (HAE)
-
Patient Perspectives on the Treatment Burden of Injectable Medication for Hereditary Angioedema
Hereditary Angioedema (HAE)
-
Insights into the Treatment Burden of Hereditary Angioedema in the Evolving Treatment Landscape
Hereditary Angioedema (HAE)
This website is intended for US healthcare professionals only.
